The future: Peptide Hormones

:sulk: OK, guess I'm not gonna get any help/info on the protocols for the "hGH Protein Peptide “Weight-Loss” Fragment #177-191", so can anyone at least point me in the right direction? :dunno: ...The company is more than a bit lacking on info... :help:
 
Ok now this is probably seen from the good side of it but anyways.

HGH Fragment 177-191
The HGH Fragment is a modified form (Figure 1) of amino acids 177-191 at the C-terminal region of the human growth hormone

(hGH).

Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one

end of the GH molecule. This region, which consists of amino acids 177-191, is less than 10% of the total size of the GH molecule and

appears to have no effect on growth or insulin resistance. It works by mimicking the way natural hGH regulates fat metabolism but

without the adverse effects on blood sugar or growth that is seen with unmodified hGH. Like unmodified GH, the HGH fragment

177-191 stimulates lipolysis and inhibits lipogenesis both in laboratory testing and in animals and humans. The HGH fragment does

not appear to affect appetite.

In laboratory tests on fat cells from rodents, pigs, dogs, and humans, the HGH fragment released fat specifically from obese fat cells

but not from lean ones, reduced new fat accumulation in all fat cells, enhanced the burning of fat. In rodents (rats and mice), HGH

fragment reduced body fat in obese animals but, enhanced fat burning without changing food consumption or inducing growth (as it

does not increase IGF levels) or any other unwanted hGH effect.
 
Back
Top